Home / Inspections / 1222107

FDA Inspection 1222107 — Abbvie Biotechnology Ltd.

Abbvie Biotechnology Ltd. — FEI 3004620772

The FDA completed an inspection of Abbvie Biotechnology Ltd. on October 30, 2023 in Barceloneta, PR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 30, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Barceloneta, PR (United States)

Facility

Other inspections at this facility

  • 1084057 (VAI Mon Mar 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1055102 (VAI Fri Jun 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1012249 (VAI Fri Apr 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 969277 (VAI Thu Mar 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 887947 (VAI Wed Jul 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources